About
Veru Inc (NASDAQ:VERU) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 9 2026
Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
Feb 19 2026
Veru to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Feb 11 2026
Veru Reports Fiscal 2026 First Quarter Financial Results and Clinical Program Progress
Feb 4 2026
Veru to Report Fiscal 2026 First Quarter Financial Results on February 11th
Dec 17 2025
Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress
Financials
Revenue
$16.89 M
Market Cap
$39 M
EPS
-1.21
Google Übersetzer